Shangxian Minimal Invasive (SMI) was established in 2010 dedicated to providing quality products for GI tract disease diagnosis and treatment with registered funds of US$3.5 million.
A series of products with patents has been developed and strict quality control system has been adopted. Products from the company meet ISO 13485 and CFDA requirements and recognized by CE system.
Our GMP workshop takes up 1200sqm composing of production, detecting, and packing functions.
Shangxian Minimal Invasive will keep providing great service to customers. We hope to explore markets worldwide with our partners, meet the needs of market with diversification, quality and superior service.